Eosinophil cationic protein (ECP) and ECP/eosinophil ratio were measured in 223 apparently healthy subjects. The serum sample for ECP measurement was obtained by standardized clotting of the blood sample for 2 hours at 3TC. Eosinophil count, ECP concentration and ECP/eosinophil ratio were no different between men (n = 122) and women (n = 10 I). Reference ranges for serum ECP and ECP /eosinophil ratio were 12-99/lg/L and 61-367 J-Lg ECP per 10 9 eosinophils, respectively. Serum ECP and blood eosinophil count were positively correlated (y= 141x+ 18, R 2=0-45, P<O·OOI). The ECP/eosinophil ratio, however, was found to decrease with increasing eosinophil count.
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The eosinophil is recognized as a pro-inflammatory cell mediating allergic symptorns.l-? Increased amounts of eosinophils may occur in blood and tissues of subjects with allergic diseases such as asthma, allergic rhinitis and atopic dermatitis. In most cases the number of eosinophils in affected tissues correlates with the severity of clinical symptoms.' 5 The eosinophil is involved in inflammation by release of granular proteins and inflammatory mediators." Eosinophil granular proteins include major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil protein X (EPX) and eosinophil peroxidase (EPO). These granular proteins Correspondence: Dr P C M Bartels.
give rise to toxic effects on a target organism or on the surrounding tissue.
It has been hypothesized that ECP, being a highly cationic protein, facilitates channelling in lipid membranes.? This feature of ECP is different from other eosinophil granular proteins, such as MBP, which probably act by crosslinking membrane structures. ECP is considered to be one of the most cytotoxic granular proteins."
Assessing the serum concentration of ECP has been suggested to be of value in the diagnosis and management of atopy. However, clinical interpretation of serum ECP is difficult as publications on this subject do not provide any information on pre-analytical conditions. Factors such as incubation time and temperature during sample processing have been demonstrated to affect the serum concentration of ECp. 8 ,9 Therefore, in this study we have determined reference values for ECP in serum, obtained under strictly defined clotting conditions.
SUBJECTS AND METHODS
Blood samples were drawn from 223 apparently healthy subjects (blood donors; 122 males and 10I females; aged 18-65 years) into plain tubes or ethylenediamine tetra-acetic acid (EDTA) tubes (Vacutainer", ref. 36-7703 SST with clot activator, and ref. 367652 with K] EDTA as an anticoagulant, Becton Dickinson, Plymouth, UK). Blood samples were allowed to clot for 120± 10 min in a water bath at 37°C. After incubation, the samples were centrifuged for 10min at 1350g at room temperature. Serum samples were separated and stored at -20°C until the ECP concentration was assayed using a radioimmunoassay kit (Kabi Pharmacia, Uppsala, Sweden). Eosinophilic granulocytes were counted on a Sysmex NE-8000 haematology analyser (Sysmex Toa, Kobe, Japan). Concentrations of immunoglobulin E (IgE) antibodies specific to inhalant allergens were estimated by radioimmunoassay (Phadiatop, Kabi Pharmacia).
Statistical methods
Statistical analysis was done using SPSS (Benelux BV, Gorinchern, The Netherlands; Windows, release 6.1). The r-test is applied to establish the statistical significance of differences in ECP concentrations, eosinophil counts and ECPjeosinophil ratios between atopic and nonatopic subjects, P values below 0·05 were considered to indicate statistical significance,
To determine reference ranges the 95% prediction intervals are calculated. Ranges for ECP and ECPjeosinophil ratio are shown in frequency distribution histograms. The reference ranges are directly determined as the estimation of the 2·5 and 97·5 percentiles.
In order to establish the correlation between eosinophil count and ECP and to indicate reference ranges for ECP concentrations in relationship with the eosinophilic granulocyte counts, regression analysis was done and the 95% prediction intervals (with confidence of 95%) were calculated. After applying curve estimation the linear model seemed to be the best fit; alternative models have lower R 2 values and are therefore less explanatory.
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For the correlation between the ECPjeosinophil ratio and the eosinophil count, the same procedure as described for the reference range of ECP with respect to the eosinophil count was performed. However, for this parameter a cubic model was applied for drawing the best fitted curve.
RESULTS
There were no significant differences between men and women in eosinophil counts [mean (SD) value for both groups was 0·16 (0' 10) x 10 9 eosinophils/L] and serum ECP concentration [40,1 (19'5) and 41'9 (23·2)J1gjL, for men and women, respectively]. The ECPjeosinophil ratios for men and women were also similar [166 (76) and 183 (83) J1gjl0 9 cells, respectively]. Consequently, results obtained for men and women were combined to establish the following reference ranges: for ECP, 12-991IgjL; and for ECPjeosinophil ratio, 61· 3671lg ECPjl09 eosinophils ( Fig. I) .
Serum ECP and eosinophil counts were correlated ( Nobody in this group of apparently healthy subjects (n = 223) suffered from obligatory allergic complaints. Nevertheless, 23% of the subjects had a positive score for IgE antibodies specific to inhalant allergens. Thus, these subjects were regarded as atopic.
These atopic subjects had significantly higher eosinophil counts and serum ECP concentrations compared with non-atopic subjects (see Table I ). However, ECPjeosinophil ratios were not different. Although serum ECP and eosinophil counts were higher in the atopic group, these were of no value in predicting an atopic condition as there was wide overlap in the distribution of the observations between the two groups (Figs 2 and 3 ).
DISCUSSION
Eosinophil cationic protein is a granular protein that is released by the eosinophil ill vivo in the process of an allergic reaction and in vitro during clotting of the whole blood sample. Serum ECP might be useful as an indicator of allergic disease activity. The fact that the large majority of ECP measured in serum is in fact released during the dotting. process makes it necessary to thoroughly standardize the sample preparation. In the present study whole blood samples were allowed to dot for exactly 2 hours at 37 C. The reference range for serum ECP concentration using this procedure was 12991Ig/L. which is higher than that found in studies in which samples were allowed to clot at room temperature. 10 .1I Clotting at 37"C also gives better precision compared with clotting at room ternperature.! The influence of sample processing is greater in cases of eosinophilia.
Serum ECP concentrations demonstrated a positive correlation with blood eosinophil count (Fig. 2) . Therefore, we calculated the ECP/ eosinophil ratio and determined the reference interval of this ratio. The relationship between ECP/eosinophil ratio and eosinophils is important to determine the activation grade per eosinophil. Whereas ECP showed a positive correlation with eosinophil count, the ECPI eosinophil ratio was negatively correlated with eosinophil count. In particular, at eosinophil counts below 0·2 x 10Y/L a parabolic increase was apparent. An overall reference range from 61-367 /-lgl IOY cells was found and in Fig. 3 the 95% prediction area for the ECP/eosinophil ratio with respect to the eosinophil count is indicated.
The decreasing trend of the ECPleosinophil ratio may be explained by the relatively high basal amount of ECP, which has been already secreted in I'ivo, in subjects with rather low eosinophil counts. Another explanation might be that in subjects with high eosinophil counts the turnover rate of the eosinophils is higher when compared with subjects with low eosinophil counts. In the case of a high turnover rate, eosinophils in the blood circulation are relatively young cells which might release a substantially smaller amount of ECP per eosinophil than relatively older cells (EF Knol, unpublished data).
We demonstrated an atopic constitution in about 23% of apparently healthy subjects on the basis of a positive score for IgE antibodies specific to inhalant allergens.'? Information concerning the frequency of positive scores for specific IgE to inhalant allergens in adult subject populations is rare. Kerkhof et al.!] reported that 32% of the Dutch population had detectable amounts of specific IgE antibodies to common aeroallergens, whereas in about 20% of a French group positive Phadiatop tests were observed. 14 In atopic subjects significantly higher ECP values and eosinophil counts were demonstrated in comparison with non-atopic subjects (see Table I ). This increase in ECP serum concentrations in atopic subjects, who have never had specific complaints due to allergic disease, is surprising and can be explained by the higher blood eosinophil counts in this group.' Nonatopic and atopic subjects showed similar ECPI eosinophil ratios, suggesting that the eosinophils of the atopic subjects are not pre-activated enough to release an increased amount of ECP per eosinophil.
In agreement with results from other studies.'! we conclude that the sensitivity and specificity of eosinophil count, ECP serum concentrations
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and ECPleosinophil ratio to detect allergic constitution for an asymptomatic subject is rather poor. In subjects with an active state of allergy more ECP per eosinophil is expected to be released. This is currently under investigation in a longitudinal study in subjects with eosinophil-related diseases.
